Florida H1281 prohibits discriminatory practices against 340B entities and 340B drugs.

Florida H1281 aims to prevent discriminatory practices against 340B entities and 340B drugs. It prohibits manufacturers from interfering with the acquisition or delivery of 340B drugs to pharmacies under contract with 340B entities. The bill also restricts health insurers and pharmacy benefit managers from imposing different terms or conditions on 340B entities compared to non-340B entities. Violators face penalties under the Florida Deceptive and Unfair Trade Practices Act. The act does not apply to the Medicaid program when it reimburses for covered outpatient drugs.

Florida H1281 prohibits discriminatory practices against 340B entities and 340B drugs.

Florida H1281 aims to prevent discriminatory practices against 340B entities and 340B drugs. It prohibits manufacturers from interfering with the acquisition or delivery of 340B drugs to pharmacies under contract with 340B entities. The bill also restricts health insurers and pharmacy benefit managers from imposing different terms or conditions on 340B entities compared to non-340B entities. Violators face penalties under the Florida Deceptive and Unfair Trade Practices Act. The act does not apply to the Medicaid program when it reimburses for covered outpatient drugs.